These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 25912969)
1. Breast Necrosis after Chemotherapy for Recurrent Ovarian Cancer: Report of a Case and Review of the Literature. Matloob R; Alikhasi A; Shirkhoda M; Najafi M Breast J; 2015; 21(4):418-22. PubMed ID: 25912969 [TBL] [Abstract][Full Text] [Related]
2. A case of bowel perforation after neoadjuvant chemotherapy for advanced epithelial ovarian cancer. Carter J; Durfee J Gynecol Oncol; 2007 Dec; 107(3):586-9. PubMed ID: 17949798 [TBL] [Abstract][Full Text] [Related]
3. Avascular necrosis following extensive chemotherapy and dexamethasone treatment in a patient with advanced ovarian cancer: case report and review of the literature. Gogas H; Fennelly D Gynecol Oncol; 1996 Dec; 63(3):379-81. PubMed ID: 8946875 [TBL] [Abstract][Full Text] [Related]
4. [A case of primary breast cancer responding to pre-operative chemotherapy with the combination of paclitaxel and carboplatin for ovarian cancer]. Kitagawa D; Nako Y; Honda Y; Shigekawa T; Horiguchi K; Aruga T; Yamashita T; Kuroi K Gan To Kagaku Ryoho; 2012 Jun; 39(6):1013-6. PubMed ID: 22705705 [TBL] [Abstract][Full Text] [Related]
5. Neutropenic enterocolitis in an advanced epithelial ovarian cancer patient treated with paclitaxel/platinum-based chemotherapy: a case report and review of the literature. Gadducci A; Gargini A; Palla E; Fanucchi A; Genazzani AR Anticancer Res; 2005; 25(3c):2509-13. PubMed ID: 16080485 [TBL] [Abstract][Full Text] [Related]
6. The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy: a retrospective cohort study. Sfakianos GP; Numnum TM; Halverson CB; Panjeti D; Kendrick JE; Straughn JM Gynecol Oncol; 2009 Sep; 114(3):424-6. PubMed ID: 19552944 [TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in early breast cancer. Groenvold M Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024 [TBL] [Abstract][Full Text] [Related]
8. [Metastatic brain tumor after chemotherapy of ovarian cancer]. Fukuda K; Chen JT; Fujimoto I; Yamauchi K; Hasumi K; Masubuchi K; Sakamoto A Gan No Rinsho; 1987 Jan; 33(1):115-8. PubMed ID: 3102810 [TBL] [Abstract][Full Text] [Related]
9. The trajectory of fatigue in adult patients with breast and ovarian cancer receiving chemotherapy. Payne JK Oncol Nurs Forum; 2002 Oct; 29(9):1334-40. PubMed ID: 12370703 [TBL] [Abstract][Full Text] [Related]
10. Breast necrosis following left internal mammary artery harvest: a case series and a comprehensive review of the literature. Wong MS; Kim J; Yeung C; Williams SH Ann Plast Surg; 2008 Oct; 61(4):368-74. PubMed ID: 18812704 [TBL] [Abstract][Full Text] [Related]
11. [Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities]. du Bois A; Lück HJ; Meerpohl HG Zentralbl Gynakol; 1997; 119(7):299-323. PubMed ID: 9340970 [TBL] [Abstract][Full Text] [Related]
12. Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer. Nurgalieva Z; Xia R; Liu CC; Burau K; Hardy D; Du XL Am J Ther; 2010; 17(2):148-58. PubMed ID: 19417586 [TBL] [Abstract][Full Text] [Related]
13. [A case and literature review of ovarian carcinosarcoma with long-term survival after repeated recurrences]. Asano M; Hasegawa K; Tsukada K; Tada S; Mizoguchi Y; Imaeda Y; Ikeda M; Kawamura K; Fujii T Gan To Kagaku Ryoho; 2014 Aug; 41(8):1031-6. PubMed ID: 25132040 [TBL] [Abstract][Full Text] [Related]
14. Relapsing Clostridium difficile toxin-associated colitis in ovarian cancer patients treated with chemotherapy. Satin AJ; Harrison CR; Hancock KC; Zahn CM Obstet Gynecol; 1989 Sep; 74(3 Pt 2):487-9. PubMed ID: 2761938 [TBL] [Abstract][Full Text] [Related]
15. [Ovarian metastasis of breast cancer: a case report. Role of cytoreductive surgery]. Dubois N; Willems T; Myant N J Gynecol Obstet Biol Reprod (Paris); 2009 May; 38(3):242-5. PubMed ID: 19304411 [TBL] [Abstract][Full Text] [Related]
17. Hormonal treatment of a recurrent granulosa cell tumor of the ovary: case report and review of the literature. Hardy RD; Bell JG; Nicely CJ; Reid GC Gynecol Oncol; 2005 Mar; 96(3):865-9. PubMed ID: 15721440 [TBL] [Abstract][Full Text] [Related]
18. A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma: a Gynecologic Oncology Group study. Feun LG; Blessing JA; Major FJ; DiSaia PJ; Alvarez RD; Berek JS Gynecol Oncol; 1998 Dec; 71(3):410-5. PubMed ID: 9887240 [TBL] [Abstract][Full Text] [Related]
19. Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study. Aerts JG; Swieboda-Sadlej A; Karanikiotis C; Labourey JL; Galid A; Wheeler T; Pujol B; Van Belle S Curr Med Res Opin; 2012 Jul; 28(7):1089-99. PubMed ID: 22642866 [TBL] [Abstract][Full Text] [Related]
20. Systemic thromboembolism after anti-cancer chemotherapy in a woman with ovarian germ cell tumor. Yanazume S; Tsuji T; Matsuo T; Kamio M; Terao S; Douchi T J Obstet Gynaecol Res; 2013 Mar; 39(3):742-5. PubMed ID: 23148694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]